| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |